80 related articles for article (PubMed ID: 16061983)
1. Plaque-reduction assays for human and simian immunodeficiency virus neutralization.
Nordqvist A; Fenyö EM
Methods Mol Biol; 2005; 304():273-85. PubMed ID: 16061983
[TBL] [Abstract][Full Text] [Related]
2. A new cell line-based neutralization assay for primary HIV type 1 isolates.
Shi Y; Albert J; Francis G; Holmes H; Fenyö EM
AIDS Res Hum Retroviruses; 2002 Sep; 18(13):957-67. PubMed ID: 12230938
[TBL] [Abstract][Full Text] [Related]
3. Quantitative evaluation of HIV and SIV co-receptor use with GHOST(3) cell assay.
Vödrös D; Fenyö EM
Methods Mol Biol; 2005; 304():333-42. PubMed ID: 16061987
[TBL] [Abstract][Full Text] [Related]
4. CD4-independent use of the CCR5 receptor by sequential primary SIVsm isolates.
Laurén A; Vincic E; Hoshino H; Thorstensson R; Fenyö EM
Retrovirology; 2007 Jul; 4():50. PubMed ID: 17645788
[TBL] [Abstract][Full Text] [Related]
5. An improved plaque reduction virus neutralization assay for human metapneumovirus.
de Graaf M; Herfst S; Schrauwen EJ; van den Hoogen BG; Osterhaus AD; Fouchier RA
J Virol Methods; 2007 Aug; 143(2):169-74. PubMed ID: 17420056
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of human and simian immunodeficiency virus plaque and neutralization assays.
McKeating JA; McKnight A; McIntosh K; Clapham PR; Mulder C; Weiss RA
J Gen Virol; 1989 Dec; 70 ( Pt 12)():3327-33. PubMed ID: 2575137
[TBL] [Abstract][Full Text] [Related]
7. A flow cytometric method for measuring neutralization of HIV-1 subtype B and E primary isolates.
Darden JM; Polonis VR; deSouza MS; Chantakulkij S; Brown AE; Birx DL; Pattanapanyasat K
Cytometry; 2000 Jun; 40(2):141-50. PubMed ID: 10805934
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the human chemerin receptor--ChemR23/CMKLR1--as co-receptor for human and simian immunodeficiency virus infection, and identification of virus-binding receptor domains.
Mårtensson UE; Fenyö EM; Olde B; Owman C
Virology; 2006 Nov; 355(1):6-17. PubMed ID: 16904155
[TBL] [Abstract][Full Text] [Related]
9. CD4+ CCR5+ T-cell dynamics during simian immunodeficiency virus infection of Chinese rhesus macaques.
Monceaux V; Viollet L; Petit F; Cumont MC; Kaufmann GR; Aubertin AM; Hurtrel B; Silvestri G; Estaquier J
J Virol; 2007 Dec; 81(24):13865-75. PubMed ID: 17898067
[TBL] [Abstract][Full Text] [Related]
10. Neutralization kinetics of sensitive and resistant subtype B primary human immunodeficiency virus type 1 isolates.
Davis D; Donners H; Willems B; Ntemgwa M; Vermoesen T; van der Groen G; Janssens W
J Med Virol; 2006 Jul; 78(7):864-76. PubMed ID: 16721864
[TBL] [Abstract][Full Text] [Related]
11. Impact of host cell variation on the neutralization of HIV-1 in vitro.
Polonis VR; Schuitemaker H; Bunnik EM; Brown BK; Scarlatti G
Curr Opin HIV AIDS; 2009 Sep; 4(5):400-7. PubMed ID: 20048704
[TBL] [Abstract][Full Text] [Related]
12. Modulation of HIV and SIV neutralization sensitivity by DC-SIGN and mannose-binding lectin.
Marzi A; Mitchell DA; Chaipan C; Fisch T; Doms RW; Carrington M; Desrosiers RC; Pöhlmann S
Virology; 2007 Nov; 368(2):322-30. PubMed ID: 17659761
[TBL] [Abstract][Full Text] [Related]
13. Measuring HIV neutralization in a luciferase reporter gene assay.
Montefiori DC
Methods Mol Biol; 2009; 485():395-405. PubMed ID: 19020839
[TBL] [Abstract][Full Text] [Related]
14. A focus reduction neutralization assay for hepatitis C virus neutralizing antibodies.
Fournier C; Duverlie G; François C; Schnuriger A; Dedeurwaerder S; Brochot E; Capron D; Wychowski C; Thibault V; Castelain S
Virol J; 2007 Mar; 4():35. PubMed ID: 17397531
[TBL] [Abstract][Full Text] [Related]
15. Development of an efficient fluorescence-based microneutralization assay using recombinant human cytomegalovirus strains expressing green fluorescent protein.
Wang Z; Mo C; Kemble G; Duke G
J Virol Methods; 2004 Sep; 120(2):207-15. PubMed ID: 15288964
[TBL] [Abstract][Full Text] [Related]
16. Establishment of a new system for determination of coreceptor usages of HIV based on the human glioma NP-2 cell line.
Soda Y; Shimizu N; Jinno A; Liu HY; Kanbe K; Kitamura T; Hoshino H
Biochem Biophys Res Commun; 1999 May; 258(2):313-21. PubMed ID: 10329384
[TBL] [Abstract][Full Text] [Related]
17. A rapid, high-throughput vaccinia virus neutralization assay for testing smallpox vaccine efficacy based on detection of green fluorescent protein.
Johnson MC; Damon IK; Karem KL
J Virol Methods; 2008 Jun; 150(1-2):14-20. PubMed ID: 18387679
[TBL] [Abstract][Full Text] [Related]
18. Development of an improved microneutralization assay for respiratory syncytial virus by automated plaque counting using imaging analysis.
Zielinska E; Liu D; Wu HY; Quiroz J; Rappaport R; Yang DP
Virol J; 2005 Nov; 2():84. PubMed ID: 16281972
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of CCR5-mediated infection by diverse R5 and R5X4 HIV and SIV isolates using novel small molecule inhibitors of CCR5: effects of viral diversity, target cell and receptor density.
Willey S; Peters PJ; Sullivan WM; Dorr P; Perros M; Clapham PR
Antiviral Res; 2005 Nov; 68(2):96-108. PubMed ID: 16157392
[TBL] [Abstract][Full Text] [Related]
20. Development of plaque assays for adenoviruses 40 and 41.
Cromeans TL; Lu X; Erdman DD; Humphrey CD; Hill VR
J Virol Methods; 2008 Jul; 151(1):140-5. PubMed ID: 18440077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
